A Phase 1/2a Study of DB-2304 in Healthy Adults and SLE Participants — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

A Phase 1/2a Study of DB-2304 in Healthy Adults and SLE Participants — Stella

Recruiting

Back to Systemic Lupus Erythematosus (SLE) trials

Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.

Trial locations(4 sites)

United States

US03-0, Clearwater, Florida

US04-0, Irving, Texas

US02-0, San Antonio, Texas

Australia

Site AUS01-0, Melbourne, Victoria

Key details

Phase

Early testing / Safety & dosing

Sponsor

DualityBio Inc.

Enrollment target

~148 participants

Started

October 2024

Primary completion

March 2026

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

18 Years – 70 Years

Last updated December 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov